Immune checkpoint inhibitor therapy tied to cardiac event risk
(HealthDay)—Immune checkpoint inhibitor (ICI) treatment is associated with increased cardiac events among patients with lung...
Health News 2 me
healthnews2me.com
Tag: Inhibitor
Pfizer Initiates Phase 2b/3 Clinical Trial for PF-06651600, an Oral JAK3 Inhibitor, for the Treatment of Patients with Moderate to Severe Alopecia Areata
January 3, 2019 -- Pfizer Inc. (NYSE: PFE) announced today the initiation of a Phase...